is experimental evidence that numb encodes a protein (Numb) widely expressed both in rodents and humans (3) . Diverse isoforms of Numb have been described, possibly endowed with different functions (4) . Brain, liver and lung tissue extracts are especially rich in Numb protein and corresponding mRNA. Cell fractionation experiments also have shown that Numb is detectable in the soluble cytoplasmic fraction and, to a lesser extent, also in the particulate membrane fraction. Studies on the amino acid sequence of Numb, demonstrating the presence of both phospho-tyrosine (PTB) and proline-rich (PRR) binding domains, suggest that this protein might be involved in controlling cell fate decision by acting as an adapter molecule in diverse signaling cascades (3) . More recently, a role for Numb as an oncosuppressor in the homeostasis of the normal human mammary parenchyma, the loss of which is pathogenetically involved in human breast tumorigenesis, has also been revealed (5) . Specifically, loss ofNumb-mediated control on Notch signaling was demonstrated in a large proportion (50%) of breast carcinomas, due to specific Numb ubiquitination and proteasomal degradation. This would lead to decreased function of Numb as an oncosuppressor in tumor cells, and to prevalence of Notch signaling, thus leading to increased tumor cell proliferation. Furthermore, some ofthe authors ofthe current study (5) have previously shown an inverse correlation between Numb immunohistochemical expression, tumor grade and Ki67 labeling index in breast carcinomas, thus supporting a protective role for Numb in breast carcinogenesis and a possible value of the same protein as a prognostic indicator in patients harboring breast carcinoma.
On these grounds, we decided to investigate the distribution pattern of Numb in a variety of human tissues (E. Maiorano and G. Viale, unpublished observations), with special reference to the salivary gland parenchyma as an additional model of glandular secretory epithelium.
On the bases of preliminary findings of intense and specific immunostaining in a variety of samples from normal salivary glands, this study aims at extensively investigated the distribution pattern of Numb in normal parotid and submandibular glands and in a well-characterized series of malignant salivary neoplasms, to ascertain the prevalence of Numb expression in these tumors and its clinicopathologic correlates.
MATERIALS AND METHODS
The study population included 10 normal salivary (6 parotid and 4 submandibular) glands, 28 adenoid cystic carcinomas (ACC) and 34 mucoepidermoid carcinomas (MEC) surgically treated at the University Hospital in Bari during the years 1960-1997. The mean age of patients with carcinoma was 55 years (range: 14-84 yrs., median: 58 yrs.) with an M/F ratio of 16/15. All tumors were classified according to the W.H.O. classification of salivary gland tumors (6) . The histological grade for adenoid cystic carcinomas was determined according to Szanto et al (7) and Batsakis et ai, (8) whereas for mucoepidemoid carcinomas the grading system of Auclair et al (9) and Goode et al was applied (10) . The pertinent c1inico-pathological features of all patients are illustrated in Table I .
All specimens were fixed in 10% neutral buffered formalin for 12-24 hours, embedded in paraffin and stained with haernatoxylin and eosin (H&E). Representative samples from I ACC and from 2 normal parotid glands were snap-frozen and cryopreserved in liquid nitrogen for the evaluation of Numb mRNA expression by RT-PCR analysis.
1mmunohistoehemistry
A single paraffin block per case was selected for immunostaining based on good morphological preservation and on the presence of all the typical cytoarchitectural features of the different neoplasms (i.e.: tubular, cribriform and solid areas in ACC; squamous, secretory and intermediate cells in MEC). Five urn thick sections were cut, collected on poly-L-Iysine coated slides and immunostained for Numb and Ki-67 (Clone MIB-I, dilution I: I00; DakoCytomation, Glostrup, Denmark), after an antigen retrieval procedure in boiling 0.0 IM citrate buffer, pH 6.0, under 2 cycles of 5 minutes irradiation in a microwave oven, operating at 750 W.
A specific rabbit polyclonal antibody, not crossreactive with the Numb-like protein, was raised against the GSAAAFNGVDDGRLAS peptide of the Numb protein, (II) and used at a concentration of 2 ug/ml, The tissue sections were incubated with the primary antibodies overnight at 4 0C and then sequentially reacted with the EnVision detection system (DakoCytomation), for 30 minutes at room temperature. The diaminobenzidine (DAB) chromogenic substrate was used for detection of peroxidase activity.
Negative control sections for Numb immunostaining were treated with the pre-absorbed rabbit antiserum, and were consistently unstained.
Evaluation ofNumb and Ki-67 immunoreactivity
In all carcinomas Numb and Ki-67 immunoreactivity was semi-quantitatively evaluated in the neoplastic component only, taking into account the percentage of immunostained cells over the total number of neoplastic epithelial cells in 20 randomly selected high power (x400) fields (HPF). In addition, Numb immunoreactivity was scored in 4 prospectively defined subclasses, as absent (no immunoreactive cells), focal (1-9% immunoreactive cells), moderate (10-50% immunoreactive cells) and diffuse (>50% immunoreactive cells), while a continuous scale (0-100%) was adopted for Ki-67 immunoreactivity.
Semi-quantitative evaluation of Numb immunoreactivity in the cyto-architecturally different areas (tubular, cribriform and solid in ACC; secretory, intermediate and squamous in MEC) of the neoplasms was also performed by using the above procedure in 3 different HPF of each growth pattern.
RNA extraction and RT-PCR analysis
The frozen tissue samples were pulverized to fine powder and cellular RNA extracted using Trizol (Gibco BRL, Life Technologies Italia, Milan, Italy) and the standard acid-guanidinium-phenol-chloroform method. The RNA concentrations were determined by optical density at 260 nm and quality tested by I% denaturing agarose gel electrophoresis.
Total RNA (500 ng) was reverse-transcribed at 37°C for 60 min., in a solution containing 50 mMTris-HCI (pH 8.3), 75 mM KCI, 10 mM DTT, 3 mM MgCI 2 , 0.5 mM of each deoxynucleotide triphoshate, 20 units of RNasin (Promega Corp, Madison, WI, USA), 2.5 IlM of random hexamers (Perkin Elmer Italia, Monza, Milan, Italy) and 200 units of Moloney Murine Leukaemia virus Reverse Transcriptase (Gibco BRL) in a total volume of 20 Ill. The cDNA was incubated at 95°C for 5 minutes to inactivate the reverse transcriptase. The efficiency of cDNA synthesis for each sample was estimated by PCR with~-actin specific primers.
To amplify the cDNA, 3 III aliquots of reversetranscribed cDNA were subjected to PCR in 50 III of IX buffer (50 mM KCI, 10 mM Tris-HCI, pH 8.3), containing 0.2 mM of each deoxynucleotide triphoshates, 1.5 mM MgCI 2 , 1.25 units of AmpliTaq DNA polymerase (Perkin Elmer) and 0.25 IlM of each primer. Human Numb mRNA was amplified using the primer pair 5'-GGCTGTTGTGACACGGAATG-3' and 5' -GTTAAAGCAGTTCTGTGGGT-3' (amplicon size: 349bp).~-actin mRNA was amplified using the primer pair 5'-GAAATCGTGCGTGACATTAAG-3 , and 5'-CTAGAAGCATTTGCGGTGGA-3' (amplicon size: 51Ibp). After denaturation for 4 min at 94°C, the samples underwent 25 cycles of amplification (for~-actin) and 28 cycles (for Numb). Each cycle included 30 sec at 94°C and I min at 60°C. In the final cycle, the temperature was held at noc for 7 minutes. PCR products were run on a 2% NuSieve 3: I agarose gel (FMC, Rockland, Maine, USA) and visualized by ethidium bromide staining.
Statistical analyses
All statistical analyses were carried out using the SAS statistical software (SAS System, release 6.08, SAS Institute Inc., Cary, NC, USA). Pearson's correlation coefficients were used for examining the associations between different measures (12) .
For the purpose of correlations, Ki-67 immunoreactivity was considered both as continuous variable and dicotomized according to 10% threshold as the best discriminant between prognostically different groups.
For overall survival (OS) the end-point of the analysis was death from any cause (13) , subjects still alive at the end ofthe study or known to be alive at some time and lost to follow-up were right censored.
For disease-free survival (DFS), the end-point of the analysis was death from any cause or alive with recurrence; subjects still alive and free of disease at the end of the study or known to be alive and free of disease at some time and lost to follow-up were right censored. Plots of the estimated survival function against time were drawn. For comparison of survival curves, two rank tests (Wilcoxon and Log-Rank) were adopted (14) .
The Cox proportional hazard regression model (15) was used to evaluate the effect of explanatory variables on survival time. For each of the variables presented in the multivariate models (-2 Log likelihood), P-values, which express the significance for inclusion of the factor into the model, were presented. All P-values were based on twosided testing.
RESULTS

Normal salivary glands
Almost all the epithelial (luminal) cells of lobar, interlobular, striated and intercalated ducts ofnormal parotid and submandibular glands consistently displayed an intense immunoreactivity for Numb (Fig. 1) . The staining was both cytoplasmic and membranous, and it was particularly enhanced at the apical and lateral membranes of ductal cells.
In submandibular glands, scattered acinar cells also demonstrated a weaker cytoplasmic staining, at variance with mucous-producing cells and parotideal acinar cells, which failed to exhibit any Numb immunoreactivity. Also, a few triangular cells intermingled with submandibular acinar cells showed definite Numb immunoreactivity.
Adenoid cystic carcinomas
Overall , 5 cases demonstrat ed diffuse (more than 50% neoplastic cells), 14 cases moderate (10-50% neoplastic cells) and 9 cases focal (less than 10% neoplastic cells) Numb immunoreactivity, with a cytoplasmic and membranous distribution overlapping the stain ing pattern of normal salivary gland s.
The different growth patterns of ACC, however, showed variable Numb immunoreactivity. Tubular structures ( Fig. 2a ), invariably present in all tumors, exhibited Numb immunoreactivity in all but one case; the staining was diffuse in 16 cases, moderate in 6 and focal in 5 cases. Conversely, cribriform areas ( Fig. 2b) , detectable in 24 neoplasms, showed immunoreactivity in only 6 (25%) cases. The staining was diffuse in 1 case, moderate in 3 and focal in 2 cases. Solid areas (Fig. 2c) , occurring in 18 cases, were mostly devoid of Numb immunoreactivity (17 of 18 cases), showing focal staining in an individual case only.
As to Ki-67 immunoreactivity, the Number of immunoreactive cells varied from 2 to 25% (mean: 15.46%; median: 15), with 4 cases showing less than 10% immunoreactive cells, and the remaining containing 10% or more Ki-67-positive cells.
Mucoepidermoid carcinomas
Overall, 8 tumor s displayed diffuse, 5 moderate and 21 focal Numb immunoreactivity.
All tumors were composed of an admixture of secretory glandular structures, intermediate cells and squamous cells in variable proportions. Secretory structures (Fig. 3a) showed diffuse cytoplasmic staining in 18 cases, moderate in 6, and focal in 9 cases. In the remaining case, this neoplastic component was unreacti ve. Intermediate cells demonstrated diffuse Numb immunoreactivity in 6 cases, moderate in 4 and focal in 20 cases. In the remaining 4 cases, this component was unstained (Fig. 3b ). Finally, the squamous cell component was consistently devoid ofNumb immunoreactivity (Fig.  3c) , with the exception of 2 cases showing staining in more than 50% neoplastic cells.
As to Ki-67 immunoreactivity, the percentage of immunoreactive cells varied from 3 to 75% (mean: 20.2%; median : 15.5), with 9 cases showing less than 10% immunoreactive cells, and the remaining containing 10% or more Ki-67-positive cells.
NUMB mRNA exp ression
A 350 bp amplification product of Numb mRNA was detected in both the normal salivary gland and the adenoid cystic carcinoma examined by RT-PCR with similar expre ssion levels (Fig. 4) . The neoplastic sample corresponded to a well differentiated ACC showing diffuse and intense Numb immunoreactivity in the corresponding histological preparation. was determined between Ki-67 immunoreactivity and tumor grade in ACC (P=0.002) (Table II) . No correlations were detected with the age and sex ofthe patients, or the site, size and stage of the neoplasms.
Statistical analyses
Using the proportional regression model, no significant differences in the overall survival (OS) or disease-free survival (DFS) between patients with ACC and MEC were detected . Accordingly, the final analysis was performed considering all 62 patients as a single group and the results were adjusted for tumor type (ACC/ MEC). Recurrent tumors were detected in 28 patients and metastases in 6. Twelve patients died during the follow-up period (mean: 80 months , median : 62 months ), II from cancer and 1 from an unrelated cause , with the reaminin gl6 patients being alive and disease-free at the end of follow-up .
Tumor site (parotid vs. minor salivary glands vs. submandibular) (P=0.027 ) and low (10% or less) Ki-67 labeling index (continuous scale) (P=O.Ol) were associated with prolonged OS in univariate analysis but these associations were lost in multivariate analysis (Table III) .
Low tumor grade (P=0.012), low Ki-67 labeling index (P=0.02) and diffuse (>50% immunoreactive cells) Numb immunoreactivity (P=0.004) were associated with prolonged DFS in univariate analysis. However, only Numb immunoreactivity and tumor stage retained statistical significance (P=O.O 17 and P> 0.034 respecti vely) in multivariate analysis, after multiple adjustments, while the percentage of Ki-67 immunoreactive cells only approached statistical significance (P=0.052).
In addition , in a multivariate model including simultaneously Numb and Ki-67 immunoreactivities, the subset of patients with diffuse Numb immunoreactivity and low Ki-67 labeling index showed prolonged DFS, as opposed to patients with reduced «50%) Numb immunoreactivity and/or high Ki-67 labeling index (Fig. 5 ).
DISCUSSION
In this study the expression pattern of the Numb protein, and the corresponding mRNA levels, have been fully characterized in both normal and neoplastic salivary glands. Typically, normal parotid and submandibular glands exhibited intense Numb immunohistochemical expression in luminal ductal cells, whereas submandibular acinic cells demonstrated weaker immunoreactivity; parotideal acinic cells and submandibular mucous-producing cells were unreactive. The immunoreactivity was reinforced at the apical and lateral borders of the epithelial cells, although a sustained cytoplasmic staining was detectable as well.
These data suggest that Numb expression in normal salivary glands is cell-type specific and subcellularly compartmentalized, as already put forward by fractionation studies in tissue extracts (3) .
All carcinomas retained at least focal Numb immunoreactivity, although a down-regulation of this protein was apparent in different tumors and in different cyto-architectural compartments of individual tumor types. In ACC, tubular structures showed the highest percentages of NUMB immunoreactive cells, whereas solid areas in all but one case were characterized by consistent downregulation of Numb expression. In addition , we detected a significant inverse correlation between Numb immunoreactivity and tumor grade. Numb levels were also inversely correlated with the tumor proliferative fraction, as determined by Ki-67
Log-rank test P=0.002
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Log-rank test P=0.002 immunostaining. These findings suggest that Numb expression in ACC is strictly correlated with aberrant tumor cell differentiation and proliferation, and that tubular areas are indeed the most differentiated structures in these neoplasms.
Ki
Our results corroborate the conclusions of previous studies (7, 8, 16) which emphasized the importance of the cyto-architectural patterns for the assessment of the histological grade of ACe. Tubular structures were indeed identified as a marker of better differentiation of the neoplasm, as opposed to the solid growth pattern. The same studies also showed that the histological grade predicts survival in patients with salivary ACe.
Most MEC (21 of 32 cases) displayed only focal Numb immunoreactivity. In most instances (24 of 32 cases) immunoreactivity was confined to the glandular secretory component, whereas the squamous cell component was devoid of immunoreactivity in 32 of 34 cases. As for ACC, a statistically significant inverse correlation between Numb immunoreactivity and histological grade was determined. Of note, an inverse correlation between Numb levels and differentiation status has also been observed in human breast cancers, in which loss of Numb has been shown to playa causative role in determining the malignant phenotype, likely through the subversion of the biological antagonism between Numb and Notch (5) . Thus, we speculate that loss of Numb might be involved also in salivary gland carcinogenesis, in agreement with a previous report that Notch is effective in deregulating cell differentiation in the salivary gland of transgenic mice (17) . Accordingly, Numb might be a major determinant of proper cell differentiation in salivary gland tissues because, as in human mammary glands, loss of Numb control over Notch signaling may induce tumor cells to maintain an immature state and acquire a proliferative advantage. This hypothesis is further supported by the detection of an increased Ki-67 labeling index in salivary gland neoplasms displaying down-regulated Numb expression.
Though several different grading systems, based on cell differentiation and architectural growth patterns have been suggested for MECs, (10, (18) (19) (20) there are sti1l controversies about how to best grade these neoplasms. Numb immunoreactivity may provide a simple and reliable parameter to more (18, 20, 22 ) ACCs (7-8, 16, 21) . Despite a statistically significant correlation of low tumor grade and diffuse Numb immunoreactivity, the latter retained an independent prognostic value for DFS at multivariate analysis, for both ACC and MEC. In addition, using an appropriate multivariate model, we were able to demonstrate that the most powerful predictors of DFS for salivary gland carcinomas result from the combined evaluation ofboth Numb and Ki-67 immunoreactivity and that patients harboring tumors 
